Finds that radiographic progression predicts poor survival in metastatic castration-resistant prostate cancer, indicating the need for regular imaging follow-up.
Radiographic progression at mCRPC diagnosis is an independent prognostic factor for poor survival. Reliance on PSA kinetics alone may underrecognize relevant progression, suggesting the importance of regular imaging follow-up. However, because PSA-based and radiographic assessments were not directly compared, this finding should be interpreted with caution.
No takes yet. Share an insight, caveat, or question.
Iwamoto et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: